FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for INTUNIV (guanfacine) submitted by Takeda Pharmaceuticals America, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Intuniv (guanfacine hydrochloride)

Snippet

SUPPL AP for INTUNIV (GUANFACINE)